Ipratropium Bromide Inhalation Aerosol
Product Images NDC 17270-0401

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide Inhalation (NDC 17270-0401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armstrong Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton label for Ipratropium Bromide HFA Inhalation Aerosol, 17 mcg/actuation. The label shows the product name, strength, and dosage form, noting 200 metered actuations totaling 12.9 grams. It is distributed by Armstrong Pharmaceuticals, Inc., Canton, Massachusetts, U.S.A., and manufactured in the USA. The label includes usage instructions, storage conditions, warnings, and a note about the included dose indicator.*

FDA Label Image

Figure3 (Figure3)

An instructional line drawing showing a person using an inhaler device by holding it to their mouth and inhaling. The image is labeled 'Figure 3' and illustrates proper inhalation technique for respiratory aerosol medication.*

FDA Label Image

Figure4 (Figure4)

An instructional illustration showing a person using an inhaler device for respiratory inhalation. The diagram includes an arrow indicating pressing down on the inhaler canister while the mouthpiece is placed in the person's mouth, demonstrating the correct technique for administering the aerosol dose.*

FDA Label Image

Figure5 (Figure5)

Illustration demonstrating the correct use of Ipratropium Bromide Inhalation Aerosol. The figure shows a person holding the inhaler with their fingers positioned on the canister and mouthpiece directed towards the mouth, indicating the proper inhalation technique for respiratory administration.*

FDA Label Image

Figure6 (Figure6)

An instructional illustration shows a hand holding an aerosol inhaler under a running water faucet, demonstrating rinsing or cleaning of the inhaler mouthpiece. Small particles are depicted falling away from the inhaler as water flows over it.*

FDA Label Image

Figure7 (Figure7)

Illustrations labeled Figure 7a and Figure 7b depict the dosage counter window of an inhaler device. Figure 7a shows the counter displaying 20, 40, and 60 dose increments, while Figure 7b shows the counter indicating 0 and 20.*

FDA Label Image

Figure1and2 (Figures1and2)

An instructional diagram showing an inhaler device for Ipratropium Bromide Inhalation aerosol. Figure 1 labels the parts: canister, mouthpiece, dose indicator, and dustcap. Figure 2 shows a dose counter scale ranging from 0 to 200 with intervals marked by tens, indicating remaining doses.*

FDA Label Image

Results (Results)

Two line graphs depicting FEV1 (liters) over 8 hours after drug administration, labeled Day 1 and Day 85, comparing placebo and three doses of ipratropium bromide inhalation: HFA 42 mcg, HFA 84 mcg, and CFC 42 mcg. The graphs show FEV1 improvements with ipratropium bromide compared to placebo over time on both days.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of ipratropium bromide, showing its molecular formula C20H30BrNO3•H2O and molecular weight 430.4.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.